Search:

< Go Back

Ultrasound as effective as CT in diagnosing kidney stones without added radiation risk: AHRQ-funded study
Wellness Living Laboratory (WELL) to be First-Ever Research Study to Examine Impacts of Dietary and Lifestyle Habits on Wellness and Healthy Aging
Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered Unsuitable
Heart Attack Global Clinical Trials Review, H2, 2014
PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014
ZERO Taps Former DOD Research Head For Board Of Directors, Names New Vice Chair
Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study
Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C.
BioClinica to Present at 20th Annual SCDM Conference
Cervical Disc Clinical Trial for People with Neck and Arm Pain Set to Begin at Hospital for Special Surgery
TransCelerate BioPharma Inc. Publishes Risk-Based Monitoring Recommendations for Central Monitoring and Technology Considerations
CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies
Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System
Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit
Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin
Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma
Cardiorentis Announces Euro 45 Million Financing with HealthCare Royalty Partners to Fund Ularitide Registration Program in Acute Heart Failure
ImmunoCellular Therapeutics Receives Positive Regulatory Feedback on ICT-107 Supporting Advancement to Registrational Phase III Testing in Newly Diagnosed Glioblastoma
MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development
Debiopharm Diagnostics Portfolio Company Biocartis Ships its First Idylla Instrument
Boston Scientific Receives CE Mark For The Vercise™ Deep Brain Stimulation (DBS) System For Treating Patients With Tremor
ROX Medical presents positive data for CONTROL-HTN resistant hypertension trial
Oncolytics Biotech® Inc. Announces Overall and KRAS-Mutated Patient Data from U.S. Randomized Phase 2 Pancreatic Cancer Study
InspireMD Announces Positive Results from CGuard™ CARENET Trial with 0% MACE reported at 30 Days
Jhpiego Announces Ebola Response Initiative
Cardioxyl Presents Oral Heart Failure Treatment Data For Its Experimental HNO Prodrug At HFSA 18th Annual Scientific Meeting
Data Published Online in The Journal of Clinical Psychiatry Show Long-Term Benefit of Non-Drug NeuroStar TMS Therapy® in Patients with Treatment Resistant Depression
Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine
HIV Clinical Pharmacist Improved Medication Adherence, Lowered Viral Loads
Global Medicines for Russia
DNAtrix Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial
Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency
Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014
Parion Sciences Announces $3 Million Award from Cystic Fibrosis Foundation Therapeutics to Accelerate the Development of Novel CF Treatment
Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data
Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER
Mylan Commences Phase III Clinical Trials for its Generic Version of Advair Diskus® and Insulin Analog to Lantus®
EYLEA® (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic Retinopathy in Patients with Diabetic Macular Edema
Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease
OncoGenex Announces Completion of Patient Enrollment in the Phase 3 AFFINITY Trial of Custirsen in Combination with Cabazitaxel/Prednisone as Second-line Chemotherapy in Men with Metastatic Castrate-Resistant Prostate Cancer
Sphere Fluidics Selects Cambridge Consultants as Product Engineering Partner for Cyto-Mine™ Development
Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer
Japanese Global Health Fund Awards $33.5 Million in Grant Investments in Less Than a Year to Develop Vaccines and Drugs for Neglected Diseases English
NeuroDerm Ltd. Files Registration Statement for Proposed Initial Public Offering
Amgen Announces Results From Several New Exploratory Analyses Evaluating Long-Term Impact Of Treatment With Prolia® (Denosumab) In Postmenopausal Women With Osteoporosis
REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System
New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density
First European Patients Enrolled in QT Vascular's ENDURE Trial
Paradigm-Heart Failure a Possible Alternative to ACE Inhibitors
Lupus Research Institute Launches NYC's First Lupus Trials Fair English

< Prev Next >
PR Newswire - United Business Media